Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Bullboard Posts
Post by NuBeeInvestoron Nov 13, 2018 1:42pm
300 Views
Post# 28966544

Doubtful sales license is coming soon - Confused by NR

Doubtful sales license is coming soon - Confused by NRFirstly, I'm long on HUGE, bought in a couple rounds before IPO and trluy not trying to bash here.  I love FSD and believe in them long term and I'm not one to fuss over cents but more and more I'm doubtful that the sales license is coming soon.  I was confused by Tom's statement in the NR today that they are on the "verge of reasiness for a pre-sale inspection".  I was told by IR that the pre-sale inspection already occured in August and that we were basically waiting for HC to get back to us.

Other reasons for my concern:
- Tom moving over to FV Pharma to "focus" on obtaining the sales license makes me think they're having issues with HC
- Dr. Raza statement in CTV article hints that they are having trouble: "There is a lot of red tape," said Dr. Raza Bokhari, co-chairman and interim chief executive of FSD Pharma. "Some of the obstacles are unnecessary. It is quite burdensome."

"CTV Article

Lastly, was unaware that the full 25,000 sq feet wasn't already licensed for production

I was glad to hear that we can sell to other LPs but I keep hearing people saying that they can sell through High Tide but unless I'm mistaken, High Tide is not a LP and therefore we can't sell to them.

I'm anxiously awaiting some solid news to take us back to the days of the .70s and .80s.

If anyone has insights into the pre-sales inspection let me know,
Bullboard Posts